annual ROE:
-80.35%+43.63%(+35.19%)Summary
- As of today (July 3, 2025), MDGL annual return on equity is -80.35%, with the most recent change of +43.63% (+35.19%) on December 31, 2024.
- During the last 3 years, MDGL annual ROE has risen by +30.57% (+27.56%).
- MDGL annual ROE is now -125.31% below its all-time high of 317.48%, reached on December 31, 2009.
Performance
MDGL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-49.57%+14.34%(+22.44%)Summary
- As of today (July 3, 2025), MDGL quarterly return on equity is -49.57%, with the most recent change of +14.34% (+22.44%) on March 31, 2025.
- Over the past year, MDGL quarterly ROE has increased by +95.43% (+65.81%).
- MDGL quarterly ROE is now -101.40% below its all-time high of 3532.29%, reached on March 31, 2010.
Performance
MDGL quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MDGL ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +35.2% | +65.8% |
3 y3 years | +27.6% | +55.5% |
5 y5 years | -327.6% | -104.7% |
MDGL ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +46.5% | at high | +86.2% |
5 y | 5-year | -327.6% | +46.5% | -50.7% | +86.2% |
alltime | all time | -125.3% | +85.3% | -101.4% | +96.4% |
MDGL ROE History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | -49.57%(-22.4%) |
Dec 2024 | -80.35%(-35.2%) | -63.91%(-28.2%) |
Sep 2024 | - | -89.04%(-21.9%) |
Jun 2024 | - | -113.99%(-21.4%) |
Mar 2024 | - | -145.00%(-31.8%) |
Dec 2023 | -123.98%(-17.4%) | -212.62%(-40.8%) |
Sep 2023 | - | -358.86%(+18.7%) |
Jun 2023 | - | -302.44%(+12.9%) |
Mar 2023 | - | -267.87%(+14.9%) |
Dec 2022 | -150.12%(+35.3%) | -233.13%(+14.2%) |
Sep 2022 | - | -204.19%(+48.6%) |
Jun 2022 | - | -137.44%(+23.4%) |
Mar 2022 | - | -111.39%(+10.7%) |
Dec 2021 | -110.92%(+80.0%) | -100.59%(+10.3%) |
Sep 2021 | - | -91.23%(+10.7%) |
Jun 2021 | - | -82.38%(+14.4%) |
Mar 2021 | - | -71.99%(+19.2%) |
Dec 2020 | -61.61%(+227.9%) | -60.38%(+32.5%) |
Sep 2020 | - | -45.56%(+38.5%) |
Jun 2020 | - | -32.89%(+35.8%) |
Mar 2020 | - | -24.22%(+30.4%) |
Dec 2019 | -18.79%(+88.8%) | -18.58%(+27.7%) |
Sep 2019 | - | -14.55%(+26.0%) |
Jun 2019 | - | -11.55%(+16.3%) |
Mar 2019 | - | -9.93%(+9.2%) |
Dec 2018 | -9.95%(-65.1%) | -9.09%(-15.6%) |
Sep 2018 | - | -10.77%(-30.1%) |
Jun 2018 | - | -15.41%(-50.1%) |
Mar 2018 | - | -30.91%(-26.8%) |
Dec 2017 | -28.49%(-60.7%) | -42.21%(-37.8%) |
Sep 2017 | - | -67.87%(-20.5%) |
Jun 2017 | - | -85.38%(+8.2%) |
Mar 2017 | - | -78.91%(-33.6%) |
Dec 2016 | -72.47%(-14.1%) | -118.87%(+56.3%) |
Sep 2016 | - | -76.03%(+205.7%) |
Jun 2016 | - | -24.87%(-66.3%) |
Mar 2016 | - | -73.71%(-36.0%) |
Dec 2015 | -84.39%(-44.1%) | -115.25%(+19.3%) |
Sep 2015 | - | -96.59%(-19.2%) |
Jun 2015 | - | -119.57%(-11.8%) |
Mar 2015 | - | -135.59%(-2.4%) |
Dec 2014 | -150.86% | -138.89%(-19.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2014 | - | -173.25%(-20.8%) |
Jun 2014 | - | -218.87%(-8.7%) |
Mar 2014 | - | -239.79%(+22.7%) |
Dec 2013 | -145.29%(+3.9%) | -195.38%(-0.7%) |
Sep 2013 | - | -196.70%(+12.8%) |
Jun 2013 | - | -174.36%(+11.1%) |
Mar 2013 | - | -156.97%(-11.9%) |
Dec 2012 | -139.78%(-43.6%) | -178.11%(-19.1%) |
Sep 2012 | - | -220.27%(+7.8%) |
Jun 2012 | - | -204.37%(-1.7%) |
Mar 2012 | - | -208.01%(-1.3%) |
Dec 2011 | -247.72%(+60.0%) | -210.82%(+14.9%) |
Sep 2011 | - | -183.52%(+15.1%) |
Jun 2011 | - | -159.45%(+14.3%) |
Mar 2011 | - | -139.54%(+14.4%) |
Dec 2010 | -154.85%(-148.8%) | -122.00%(+10.0%) |
Sep 2010 | - | -110.87%(-111.0%) |
Jun 2010 | - | 1005.82%(-71.5%) |
Mar 2010 | - | 3532.29%(-1372.4%) |
Dec 2009 | 317.48%(+101.5%) | -277.61%(+128.0%) |
Sep 2009 | - | -121.77%(-195.1%) |
Jun 2009 | - | 128.11%(-39.9%) |
Mar 2009 | - | 213.20%(-46.5%) |
Dec 2008 | 157.54%(-128.7%) | 398.84%(-129.0%) |
Sep 2008 | - | -1375.78%(+354.8%) |
Jun 2008 | - | -302.47%(+83.6%) |
Mar 2008 | - | -164.70%(-4.4%) |
Dec 2007 | -548.58%(+143.0%) | -172.34%(-3.3%) |
Sep 2007 | - | -178.16%(+9.6%) |
Jun 2007 | - | -162.52%(+30.5%) |
Mar 2007 | - | -124.52%(-10.3%) |
Dec 2006 | -225.78%(+179.4%) | -138.81%(+27.9%) |
Sep 2006 | - | -108.50%(-21.0%) |
Jun 2006 | - | -137.27%(-14.0%) |
Mar 2006 | - | -159.67%(+41.4%) |
Dec 2005 | -80.81%(+71.4%) | -112.96%(+60.3%) |
Sep 2005 | - | -70.48%(+59.9%) |
Jun 2005 | - | -44.07%(+149.4%) |
Mar 2005 | - | -17.67% |
Dec 2004 | -47.15%(-32.7%) | - |
Dec 2003 | -70.01%(+404.4%) | - |
Dec 2001 | -13.88% | - |
FAQ
- What is Madrigal Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual ROE year-on-year change?
- What is Madrigal Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly ROE year-on-year change?
What is Madrigal Pharmaceuticals annual return on equity?
The current annual ROE of MDGL is -80.35%
What is the all time high annual ROE for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual return on equity is 317.48%
What is Madrigal Pharmaceuticals annual ROE year-on-year change?
Over the past year, MDGL annual return on equity has changed by +43.63% (+35.19%)
What is Madrigal Pharmaceuticals quarterly return on equity?
The current quarterly ROE of MDGL is -49.57%
What is the all time high quarterly ROE for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly return on equity is 3532.29%
What is Madrigal Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, MDGL quarterly return on equity has changed by +95.43% (+65.81%)